>

>

Platform technology technical evaluation and deal trends

Service Areas
Therapeutic Areas

Other Therapeutic Areas

Gene Therapy & Orphan Disease

Client Type

Big Pharma

Client Problems

  • A large biopharmaceutical company wanted to evaluate 3 novel platform technologies in development based on technical merits and feasibility


  • The client wanted to determine the degree to which they would integrate and harmonize with their current portfolio and disease areas of focus


  • Lastly, the client wanted to understand the competitive landscape and recent deal trends for prioritized platform(s)

What We Did

  • Performed a technical deep dive into each of the therapeutic platform technologies and its applications


  • Determined the technical hurdles , opportunities and challenges of each platform technology


  • Identified key milestones, current clinical trials and gathered competitive intelligence on the major players in the space


  • Identified top deals, partnerships, and investment trends for prioritized technologies

Our Results And Insight

  • Deep dive into each platform technology and determine its current and future applications


  • Comparison of two platform technologies for solid tumor indications


  • Identified key clinical trials for each platform technology


  • Deals and partnerships in for each platform technology

See other case studies

Commercial Strategy case studies >

Other Therapeutic Areas case studies >

Gene Therapy & Orphan Disease case studies >

Service Areas Details

Commercial Strategy (Technical Assessment)

Therapeutic Areas Details

Other Therapeutic Areas (CAR-T, CRISPR), Gene Therapy

© 2019, First Principles Advisory Group. All Rights Reserved
SF Bay Area, Denver, Seattle, New York City, Cambridge
First Principles Advisory Group
1290 Howard Street Suite 323
Burlingame, CA 94010
(415) 669-5183
info@fpadvisory.net